
Profitability, historical returns, and peer comparisons.
According to Precigen, Inc.’s latest financial reports and current stock price. The company's current ROE is 57.93%. This represents a change of -468.76% compared to the average of -15.71% of the last 4 quarters.
The mean historical ROE of Precigen, Inc. over the last ten years is -235.80%. The current 57.93% ROE has changed -124.57% with respect to the historical average. Over the past ten years (40 quarters), PGEN's ROE was at its highest in in the March 2025 quarter at 385.16%. The ROE was at its lowest in in the September 2025 quarter at -349.54%.
Average
-235.80%
Median
-113.11%
Minimum
-1198.61%
Maximum
22.43%
Discovering the peaks and valleys of Precigen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 540.12%
Maximum Annual ROE = 22.43%
Minimum Annual Increase = -460.86%
Minimum Annual ROE = -1198.61%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1198.61% | 265.68% |
| 2024 | -327.77% | 304.99% |
| 2023 | -80.93% | -460.86% |
| 2022 | 22.43% | -126.12% |
| 2021 | -85.86% | -66.18% |
| 2020 | -253.85% | 6.75% |
| 2019 | -237.79% | 69.40% |
| 2018 | -140.37% | 540.12% |
| 2017 | -21.93% | -34.17% |
| 2016 | -33.31% | 173.62% |
The current ROE of Precigen, Inc. (PGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-535.77%
5-year avg
-334.15%
10-year avg
-235.80%
Precigen, Inc.’s ROE is greater than REGENXBIO Inc. (-220.07%), greater than CRISPR Therapeutics AG (-25.59%), greater than Metagenomi, Inc. Common Stock (-63.65%), greater than Intellia Therapeutics, Inc. (-57.79%), greater than Rocket Pharmaceuticals, Inc. (-5.76%), greater than Precision BioSciences, Inc. (-58.09%), greater than Editas Medicine, Inc. (-196.63%), greater than Abeona Therapeutics Inc. (-41.69%), greater than Genprex, Inc. (-163.13%), greater than Senti Biosciences, Inc. (-1539.97%),
| Company | ROE | Market cap |
|---|---|---|
| -220.07% | $508.96M | |
| -25.59% | $5.01B | |
| -63.65% | $29.84M | |
| -57.79% | $1.72B | |
| -5.76% | $286.51M | |
| -58.09% | $224.12M | |
| -196.63% | $417.74M | |
| -41.69% | $241.32M | |
| -163.13% | $1.08M | |
| -1539.97% | $5.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precigen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Precigen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Precigen, Inc.'s ROE?
How is the ROE calculated for Precigen, Inc. (PGEN)?
What is the highest ROE for Precigen, Inc. (PGEN)?
What is the 3-year average ROE for Precigen, Inc. (PGEN)?
What is the 5-year average ROE for Precigen, Inc. (PGEN)?
How does the current ROE for Precigen, Inc. (PGEN) compare to its historical average?